UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 629

Sortiert nach

Safety and Pharmacokinetics of Escalating Daily Doses of the Antituberculosis Drug Rifapentine in Healthy Volunteers

Clinical pharmacology and therapeutics, 2012-05, Vol.91 (5), p.881-888

2012

Volltextzugriff (PDF)

The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection

Clinical infectious diseases, 2011-03, Vol.52 (6), p.793-800

2011

Volltextzugriff (PDF)

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

Clinical pharmacokinetics, 2001, Vol.40 (5), p.327-341

2001

Volltextzugriff (PDF)

CD4+ Count–Guided Interruption of Antiretroviral Treatment

The New England journal of medicine, 2006-11, Vol.355 (22), p.2283-2296

2006

Volltextzugriff (PDF)

Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and Tuberculosis

Clinical infectious diseases, 2005-05, Vol.40 (10), p.1481-1491

2005

Volltextzugriff (PDF)

Assessing the availability of life cycle assessments in Austria

The international journal of life cycle assessment, 2019-04, Vol.24 (4), p.614-619

2019

Volltextzugriff (PDF)

Treatment of HIV-related Tuberculosis in the Era of Effective Antiretroviral Therapy

American journal of respiratory and critical care medicine, 2001-07, Vol.164 (1), p.7-12

2001

Volltextzugriff (PDF)

Quality of life assessment among HIV‐positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV medicine, 2015-04, Vol.16 (S1), p.88-96

2015

Volltextzugriff (PDF)

Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis

The international journal of tuberculosis and lung disease, 2007-12, Vol.11 (12), p.1282

2007

Volltextzugriff (PDF)

Therapeutic Implications of Drug Interactions in the Treatment of Human Immunodeficiency Virus-Related Tuberculosis

Clinical infectious diseases, 1999-03, Vol.28 (3), p.419-430

1999

Volltextzugriff (PDF)

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

The Lancet (British edition), 2002-08, Vol.360 (9332), p.528-534

2002

Volltextzugriff (PDF)

Pharmacokinetics of ethambutol in children and adults with tuberculosis

The international journal of tuberculosis and lung disease, 2004-11, Vol.8 (11), p.1360

2004

Volltextzugriff (PDF)

Requirements for the clinical evaluation of new anti-tuberculosis agents in children

The international journal of tuberculosis and lung disease, 2013-06, Vol.17 (6), p.794

2013

Volltextzugriff (PDF)

Breaking the camel's back: multicenter clinical trials and local institutional review boards

Annals of internal medicine, 2001-01, Vol.134 (2), p.152

2001

Volltextzugriff (PDF)

Evaluation of the Drug Interaction between Rifabutin and Efavirenz in Patients with HIV Infection and Tuberculosis

Clinical infectious diseases, 2005-11, Vol.41 (9), p.1343-1349

2005

Volltextzugriff (PDF)

Discontinuation of Prophylaxis against Mycobacterium avium Complex Disease in HIV-Infected Patients Who Have a Response to Antiretroviral Therapy

The New England journal of medicine, 2000-04, Vol.342 (15), p.1085-1092

2000

Volltextzugriff (PDF)

Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV medicine, 2015-04, Vol.16 (0), p.64-76

2015

Volltextzugriff (PDF)

Fluoroquinolone Susceptibility among Mycobacterium tuberculosis Isolates from the United States and Canada

Clinical infectious diseases, 2005-02, Vol.40 (3), p.386-391

2005

Volltextzugriff (PDF)

Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment

The international journal of tuberculosis and lung disease, 2012-04, Vol.16 (4), p.473

2012

Volltextzugriff (PDF)

Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations

Infection, 2013-02, Vol.41 (1), p.135-144

2013

Volltextzugriff (PDF)

Pneumocystis carinii Mutations Are Associated with Duration of Sulfa or Sulfone Prophylaxis Exposure in AIDS Patients

The Journal of infectious diseases, 2000-08, Vol.182 (2), p.551-557

2000

Volltextzugriff (PDF)

Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings

The international journal of tuberculosis and lung disease, 2008-12, Vol.12 (12), p.1370

2008

Volltextzugriff (PDF)

Grade 4 events are as important as AIDS events in the era of HAART

Journal of acquired immune deficiency syndromes (1999), 2003-12, Vol.34 (4), p.379

2003

Volltextzugriff (PDF)

Review: life-cycle assessment, water footprinting, and carbon footprinting in Portugal

The international journal of life cycle assessment, 2018-08, Vol.23 (8), p.1693-1700

2018

Volltextzugriff (PDF)

Review of False-Positive Cultures for Mycobacterium tuberculosis and Recommendations for Avoiding Unnecessary Treatment

Clinical infectious diseases, 2000-12, Vol.31 (6), p.1390-1395

2000

Volltextzugriff (PDF)

1 – 25 von 629

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(533)
Mit Volltextzugriff
(521)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety and Pharmacokinetics of Escalating Daily Doses of the Antituberculosis Drug Rifapentine in Healthy Volunteers

The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

CD4+ Count–Guided Interruption of Antiretroviral Treatment

Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and Tuberculosis

Assessing the availability of life cycle assessments in Austria

Treatment of HIV-related Tuberculosis in the Era of Effective Antiretroviral Therapy

Quality of life assessment among HIV‐positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis

Therapeutic Implications of Drug Interactions in the Treatment of Human Immunodeficiency Virus-Related Tuberculosis

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

Pharmacokinetics of ethambutol in children and adults with tuberculosis

Requirements for the clinical evaluation of new anti-tuberculosis agents in children

Breaking the camel's back: multicenter clinical trials and local institutional review boards

Evaluation of the Drug Interaction between Rifabutin and Efavirenz in Patients with HIV Infection and Tuberculosis

Discontinuation of Prophylaxis against Mycobacterium avium Complex Disease in HIV-Infected Patients Who Have a Response to Antiretroviral Therapy

Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Fluoroquinolone Susceptibility among Mycobacterium tuberculosis Isolates from the United States and Canada

Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment

Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations

Pneumocystis carinii Mutations Are Associated with Duration of Sulfa or Sulfone Prophylaxis Exposure in AIDS Patients

Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings

Grade 4 events are as important as AIDS events in the era of HAART

Review: life-cycle assessment, water footprinting, and carbon footprinting in Portugal

Review of False-Positive Cultures for Mycobacterium tuberculosis and Recommendations for Avoiding Unnecessary Treatment

Suchergebnisse filtern